|
General Information
|
|
|
Product
|
ergo-1 Positive Control
|
|
Description
|
Western Blot Positive Control Endogenous-RNAi deficient arGOnaute protein
|
|
Verified Applications
|
WB
|
|
Immunogen
|
Purified Protein
|
|
Accession #
|
NCBI: NP_503362.2
|
|
Physical Properties
|
|
|
Quantity
|
5 Applications
|
|
Volume
|
Inquire
|
|
Form
|
Western Blot Positive Control
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Western Blot
|
1:500
|
|
Protein
|
|
Uniprot #
|
O61931
|
|
Overview
|
Argonaute protein required for gene silencing in the endogenous RNA interference (RNAi) pathway. Interacts with 26G small interfering RNAs (26G-siRNAs) and required for subsequent biogenesis of secondary 22G-siRNAs. May be involved in passenger strand cleavage of target 26G-siRNAs (PubMed: 22102828).
|
|
Molecular Function
|
Dead/H-box RNA helicase binding, nucleic acid binding, production of siRNA involved in RNA interference, regulation of translation, RNA interference.
|
|
Subcellular Location
|
Cytoplasm
|
|
Structure
|
Belongs to the argonaute family. Piwi subfamily. Contains 1 PAZ domain. Contains 1 Piwi domain.
|
| Expression |
Expressed in embryos and during larval development up to larval stage 2. |
|
Alternative Nomenclature
|
Endogenous RNAi deficient argonaute antibody
Ergo 1 antibody
Hypothetical protein R09A1.1 antibody
|
| |
|
ergo-1 Antibody
ergo-1 Antibody FITC
ergo-1 Blocking Peptide
ergo-1 Antibody BIOTIN
ergo-1 Antibody BIOTIN
ergo-1 Blocking Peptide
ergo-1 Antibody
ergo-1 Antibody FITC
